Form 4: Phillip Frost, OPKO Health CEO, Buys $421,565 Worth of Shares

OPKO Health's CEO, Phillip Frost, through various trusts, acquired 280,183 shares of OPKO stock at an average price of $1.5045 on November 8, 2024.

Summary

• On November 8, 2024, Phillip Frost, the CEO and Chairman of OPKO Health, Inc., acquired 280,183 shares of OPKO common stock.
• The shares were purchased at a weighted average price of $1.5045, with individual prices ranging from $1.455 to $1.545.
• The total value of the purchase is approximately $421,565.
• Following the transaction, Dr. Frost beneficially owns 3,068,951 shares directly.
• Dr. Frost also has indirect beneficial ownership through Frost Gamma Investments Trust (211,512,405 shares) and Frost Nevada Investments Trust (30,127,177 shares).
• Dr. Frost disclaims beneficial ownership of the shares held by the trusts, except to the extent of any pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment. It's a factual report of a stock purchase by the CEO. While insider buying can be seen as positive, it's not overwhelmingly so without additional context.

Positives

• The CEO's purchase of shares could be interpreted as a positive signal about the company's prospects.

Industry Context

Insider buying is often seen as a positive sign, indicating that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates